Smith Sandford D's Form 4 filing
Cytokinetics Inc (CYTK) · filed Sep 2, 2022
- Accession no.
- 0001127602-22-022049
- Filed
- Sep 2, 2022
- Trade date
- Sep 2, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $613.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Sandford DCIK 0001243004 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | Common Stock | MOption exerciseAcquired | +3,035 | $10.68 | +$32,413.8 | 15,205 | Direct | |
| Sep 2, 2022 | Common Stock | MOption exerciseAcquired | +5,834 | $24.32 | +$141,882.88 | 21,039 | Direct | |
| Sep 2, 2022 | Common Stock | MOption exerciseAcquired | +2,500 | $37.89 | +$94,725 | 23,539 | Direct | |
| Sep 2, 2022 | Common Stock | SSaleDisposed | −11,369 | $53.97 | −$613,584.93 | 12,170 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | Common Stock | MOption exerciseDisposed | −3,035 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2022 | Common Stock | MOption exerciseDisposed | −5,834 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2022 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 7,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.